Jason Jalil • UCLA Profiles (original) (raw)

  1. Polypharmacy in Treatment of Behavioral Issues in Dementia-Use of Atypical Antipsychotics. Clin Geriatr Med. 2022 11; 38(4):641-652. Jalil J, Nazarian P, von Walter HF. PMID: 36210081.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  2. Brain health consequences of digital technology use . Dialogues Clin Neurosci. 2020 06; 22(2):179-187. Small GW, Lee J, Kaufman A, Jalil J, Siddarth P, Gaddipati H, Moody TD, Bookheimer SY. PMID: 32699518; PMCID: PMC7366948.
    View in: PubMed Mentions: 77 Fields:
    Translation:Humans
  3. Health-Promoting Strategies for the Aging Brain. Am J Geriatr Psychiatry. 2019 03; 27(3):213-236. Chen ST, Volle D, Jalil J, Wu P, Small GW. PMID: 30686664.
    View in: PubMed Mentions: 11 Fields:
    Translation:Humans
  4. Natural killer T cells in advanced melanoma patients treated with tremelimumab. PLoS One. 2013; 8(10):e76829. Ibarrondo FJ, Yang OO, Chodon T, Avramis E, Lee Y, Sazegar H, Jalil J, Chmielowski B, Koya RC, Schmid I, Gomez-Navarro J, Jamieson BD, Ribas A, Comin-Anduix B. PMID: 24167550; PMCID: PMC3805549.
    View in: PubMed Mentions: 10 Fields:
    Translation:HumansCellsCTClinical Trials
  5. CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans. Clin Cancer Res. 2011 Jun 15; 17(12):4101-9. Huang RR, Jalil J, Economou JS, Chmielowski B, Koya RC, Mok S, Sazegar H, Seja E, Villanueva A, Gomez-Navarro J, Glaspy JA, Cochran AJ, Ribas A. PMID: 21558401; PMCID: PMC3117971.
    View in: PubMed Mentions: 93 Fields:
    Translation:HumansCellsCTClinical Trials
  6. The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrations. Clin Cancer Res. 2010 Dec 15; 16(24):6040-8. Comin-Anduix B, Chodon T, Sazegar H, Matsunaga D, Mock S, Jalil J, Escuin-Ordinas H, Chmielowski B, Koya RC, Ribas A. PMID: 21169256; PMCID: PMC3057460.
    View in: PubMed Mentions: 75 Fields:
    Translation:HumansCells
  7. Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanoma. PLoS One. 2010 Sep 15; 5(9):e12711. Comin-Anduix B, Sazegar H, Chodon T, Matsunaga D, Jalil J, von Euw E, Escuin-Ordinas H, Balderas R, Chmielowski B, Gomez-Navarro J, Koya RC, Ribas A. PMID: 20856802; PMCID: PMC2939876.
    View in: PubMed Mentions: 16 Fields:
    Translation:HumansCellsCTClinical Trials
  8. Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma. Clin Cancer Res. 2009 Oct 01; 15(19):6267-76. Ribas A, Comin-Anduix B, Chmielowski B, Jalil J, de la Rocha P, McCannel TA, Ochoa MT, Seja E, Villanueva A, Oseguera DK, Straatsma BR, Cochran AJ, Glaspy JA, Hui L, Marincola FM, Wang E, Economou JS, Gomez-Navarro J. PMID: 19789309; PMCID: PMC2765061.
    View in: PubMed Mentions: 108 Fields:
    Translation:HumansCellsCTClinical Trials
  9. CTLA4 blockade increases Th17 cells in patients with metastatic melanoma. J Transl Med. 2009 May 20; 7:35. von Euw E, Chodon T, Attar N, Jalil J, Koya RC, Comin-Anduix B, Ribas A. PMID: 19457253; PMCID: PMC2697137.
    View in: PubMed Mentions: 93 Fields:
    Translation:HumansCellsCTClinical Trials
  10. Intratumoral immune cell infiltrates, FoxP3, and indoleamine 2,3-dioxygenase in patients with melanoma undergoing CTLA4 blockade. Clin Cancer Res. 2009 Jan 01; 15(1):390-9. Ribas A, Comin-Anduix B, Economou JS, Donahue TR, de la Rocha P, Morris LF, Jalil J, Dissette VB, Shintaku IP, Glaspy JA, Gomez-Navarro J, Cochran AJ. PMID: 19118070.
    View in: PubMed Mentions: 71 Fields:
    Translation:HumansCells
  11. Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma. J Transl Med. 2008 May 01; 6:22. Comin-Anduix B, Lee Y, Jalil J, Algazi A, de la Rocha P, Camacho LH, Bozon VA, Bulanhagui CA, Seja E, Villanueva A, Straatsma BR, Gualberto A, Economou JS, Glaspy JA, Gomez-Navarro J, Ribas A. PMID: 18452610; PMCID: PMC2412852.
    View in: PubMed Mentions: 39 Fields:
    Translation:HumansCellsCTClinical Trials

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs